Altered cerebral energy metabolism in Alzheimer's disease: a PET study.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Nuclear Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8271029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies

  1991cited by this paper
• Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: A cross-sectional comparison against advanced late-onset and incipient early-onset cases

  1991cited by this paper
• Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss?

  1990cited by this paper
• Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease

  1989cited by this paper
• Synaptic loss in Alzheimer's disease and other dementias

  1989cited by this paper
• Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan

  1989cited by this paper
• Anatomical mapping of glucose transporter protein and pyruvate dehydrogenase in rat brain: an immunogold study.

  1989cited by this paper
• The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases.

  1988cited by this paper
• Measurement of the Ratio of Cerebral Oxygen Consumption to Glucose Utilization by Positron Emission Tomography: Its Consistency with the Values Determined by the Kety-Schmidt Method in Normal Volunteers

  1988cited by this paper
• Quantitation in Positron Emission Tomography: 8. Effects of Nonlinear Parameter Estimation on Functional Images

  1987cited by this paper
• Thalamic tumours invading the brain stem produce crossed cerebellar diaschisis demonstrated by PET.

  1986cited by this paper
• Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease

  1985cited by this paper
• Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

  1985cited by this paper
• Pathological and positron emission tomographic correlations in Alzheimer's disease.

  1985cited by this paper
• Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease

  1985cited by this paper
• Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose

  1985cited by this paper
• Performance characteristics of Positologica III: a whole-body positron emission tomograph.

  1985cited by this paper
• Cerebral Blood Flow and Metabolism in Normal Human Aging, Pathological Aging, and Senile Dementia

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• A new headholder for PET, CT, and NMR imaging.

  1984cited by this paper
• Computed Tomography and Positron Emission Transaxial Tomography Evaluations of Normal Aging and Alzheimer's Disease

  1983cited by this paper
• Correction for the Presence of Intravascular Oxygen-15 in the Steady-State Technique for Measuring Regional Oxygen Extraction Ratio in the Brain: 1. Description of the Method

  1983cited by this paper
• Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose

  1983cited by this paper
• Alzheimer's disease

  1983cited by this paper
• Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose Method

  1982cited by this paper
• Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

  1981cited by this paper
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

  1981cited by this paper
• Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading

  1981cited by this paper
• Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography: Theory, Procedure, and Normal Values

  1980cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• Oxidative metabolism of brain tumors.

  1972cited by this paper

• Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD mice

  2026cites this paper
• Simultaneous multiple post-labelling delay ASL MRI and [18F]FDG PET in a mixed memory clinic population and healthy controls.

  2026cites this paper
• Unraveling the mystery of citrate transporters in Alzheimer's disease: An updated review.

  2025cites this paper
• Early-onset total cholesterol abnormality is associated with gray matter atrophy and decreased microstructural integrity

  2025cites this paper
• Cell type-specific contributions to impaired blood-brain barrier and cerebral metabolism in presymptomatic 5XFAD mice

  2025cites this paper
• Normal cerebral oxygen consumption and lactate levels in patients with Alzheimer's disease and Lewy body dementia.

  2025cites this paper
• Sleep‐stage‐dependent alterations in cerebral oxygen metabolism quantified by magnetic resonance

  2024cites this paper
• Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer’s pathology

  2024cites this paper
• Unique tau‐ and synuclein‐dependent metabolic reprogramming in neurons distinct from normal aging

  2024cites this paper
• Recent Advances in MR Imaging-based Quantification of Brain Oxygen Metabolism

  2024cites this paper
• Oxygen extraction fraction (OEF) values and applications in neurological diseases

  2024cites this paper
• Feasibility and preliminary efficacy of different intensities of functional training in elderly type 2 diabetes patients with cognitive impairment: a pilot randomised controlled trial

  2024cites this paper
• Quantification of regional CMRO2 in human brain using dynamic 17O-MRI at 3T

  2023cites this paper
• Neural Stem Cell-based Regenerative Therapy: A New Approach to Diabetes Treatment.

  2023cites this paper
• Evaluation of whole-brain oxygen metabolism in Alzheimer's disease using QSM and quantitative BOLD

  2023influential citation
• Cerebral oxygen metabolism from MRI susceptibility

  2023influential citation
• Redox Imbalance in Neurological Disorders in Adults and Children

  2023cites this paper
• β‐Lactolin improves mitochondrial function in Aβ‐treated mouse hippocampal neuronal cell line and a human iPSC‐derived neuronal cell model of Alzheimer's disease

  2022cites this paper
• Complex processes underlying the dynamic changes of D-serine level in AD brains.

  2022cites this paper
• Site-specific mitochondrial dysfunction in neurodegeneration.

  2022cites this paper
• Longitudinal changes in brain oxygen extraction fraction (OEF) in older adults: Relationship to markers of vascular and Alzheimer's pathology

  2022cites this paper
• Pharmacologic Enrichment of Exosome Yields and Mitochondrial Cargo.

  2022cites this paper
• Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease

  2021cites this paper
• The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer’s Disease Pathology

  2021cites this paper
• Mutations in the Amyloid-β Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-β Peptide

  2021cites this paper
• Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model

  2021cites this paper
• Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [11C]PiB

  2021cites this paper
• Zero Echo Time 17O-MRI Reveals Decreased Cerebral Metabolic Rate of Oxygen Consumption in a Murine Model of Amyloidosis

  2021cites this paper
• The cerebral hypometabolism model of Alzheimer's disease explored: can a ketogenic diet improve cognition in Alzheimer's disease? A review of the literature

  2021cites this paper
• Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease.

  2020cites this paper
• Role of Insulin Resistance in the Alzheimer's Disease Progression

  2020cites this paper
• Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation

  2020cites this paper
• Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL

  2020cites this paper
• Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients

  2020cites this paper
• The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease

  2020cites this paper
• Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities

  2019cites this paper
• Role of Mitochondria in Neurodegeneration in Obesity and Type 2 Diabetes

  2019cites this paper
• Extending Arms of Insulin Resistance from Diabetes to Alzheimer's Disease: Identification of Potential Therapeutic Targets.

  2019cites this paper
• Brain Blood Flow and Metabolism: Variable Relationships in Altered Metabolic States

  2019cites this paper
• Calibrated fMRI for mapping absolute CMRO2: Practicalities and prospects

  2019cites this paper
• The sinister face of heme oxygenase-1 in brain aging and disease.

  2019cites this paper
• Quantitative positron emission tomography reveals regional differences in aerobic glycolysis within the human brain

  2018cites this paper
• Mitochondria at the Base of Neuronal Innate Immunity in Alzheimer’s and Parkinson’s Diseases

  2018cites this paper
• Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease

  2018cites this paper
• Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline

  2018cites this paper
• APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction

  2018cites this paper
• Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer’s disease

  2018cites this paper
• Mitochondrial Metabolism in Major Neurological Diseases

  2018cites this paper
• Quantification of oxygen metabolic rates in Human brain with dynamic 17O MRI: Profile likelihood analysis

  2017influential citation
• Rôle du jeûne et de la perturbation de la cascade de signalisation de l'insuline sur le clivage du précurseur de la protéine amyloïde (APP)

  2017cites this paper
• 3D CMRO2 mapping in human brain with direct 17O MRI: Comparison of conventional and proton‐constrained reconstructions

  2017influential citation
• Application of calibrated fMRI in Alzheimer's disease

  2017cites this paper
• Mitochondria as a Therapeutic Target for the Treatment of Alzheimer’s Disease

  2017cites this paper
• The emerging link between O-GlcNAcylation and neurological disorders

  2017cites this paper
• Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.

  2017cites this paper
• The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction

  2017cites this paper
• Magnetic resonance imaging of resting cerebral oxygen metabolism : applications in Alzheimer’s disease

  2017influential citation
• Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.

  2017cites this paper
• A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer’s Disease Subjects: Results of a Single-Arm, Pilot Trial

  2017cites this paper
• Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease

  2017cites this paper
• Different Scales of Cortical Organization are Selectively Targeted in the Progression to Alzheimer's Disease

  2016cites this paper
• Insulin resistance and reduced brain glucose metabolism in the aetiology of Alzheimer’s disease

  2016cites this paper
• Rubidium and potassium levels are altered in Alzheimer’s disease brain and blood but not in cerebrospinal fluid

  2016cites this paper
• Role of Hexokinase and VDAC in Neurological Disorders.

  2016cites this paper
• Novel Methods for the Detection of Functional Brain Activity using 17O MRI

  2016cites this paper
• Développement d'un serious game portant sur l'activité physique et les fonctions exécutives pour l'évaluation et la stimulation des patients présentant une maladie d’Alzheimer ou une pathologie associée

  2016cites this paper
• Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease

  2016cites this paper
• Advanced MRI Analysis for Computer-Aided Diagnosis of Dementia

  2016cites this paper
• Molecular and cellular insights into mitochondrial contributions to neuronal autophagy: links to energetics and mitophagy

  2016cites this paper
• Advanced MR Neuroimaging in Early Stage Presenile Dementia

  2016influential citation
• MRI at 7 tesla and above: Demonstrated and potential capabilities

  2015cites this paper
• Brain aerobic glycolysis functions and Alzheimer’s disease

  2015cites this paper
• Multimodal neuroimaging in humans at 9.4 T: a technological breakthrough towards an advanced metabolic imaging scanner

  2015cites this paper
• A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders

  2015cites this paper
• Reduced CMRO2 and cerebrovascular reserve in patients with severe intracranial arterial stenosis: A combined multiparametric qBOLD oxygenation and BOLD fMRI study

  2015cites this paper
• Pitfalls and Artifacts in the Use of PET/CT in Oncology Imaging.

  2015cites this paper
• Activité aérobie et environnement enrichi : perspectives pour le patient Alzheimer

  2015cites this paper
• Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism

  2015cites this paper
• Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer's disease.

  2015cites this paper
• Elusive roles for reactive astrocytes in neurodegenerative diseases

  2015cites this paper
• Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights

  2014cites this paper
• Deregulation of brain insulin signaling in Alzheimer’s disease

  2014cites this paper
• NOVEL COMPOUNDS AS POTENTIAL ALZHEIMER'S DISEASE THERAPEUTICS AND INHIBITORS OF THE NLRP3 INFLAMMASOME

  2014cites this paper
• Role of MT1/ MT2 Melatonin Membrane Receptors in Mediating the Neuroprotective Effects of Melatonin in Alzheimer's Disease

  2014cites this paper
• Fractal Analysisof Brain CT Image in Alzheimer Type Senile Dementia

  2014cites this paper
• Effect of necrosectomy and vacuum-assisted closure (VAC) on mitochondrial function and oxidative stress markers in severe acute pancreatitis.

  2014cites this paper
• Metabolism and functions of copper in brain.

  2014cites this paper
• Nucleic acid oxidation: an early feature of Alzheimer's disease

  2014cites this paper
• Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia

  2014cites this paper
• Noradrenergic Deficits Contribute to Impairment in the TgCRND8 Mouse Model of Alzheimer's Disease

  2014cites this paper
• Advancing Brain Imaging for Alzheimer's Disease: Integrating Anatomic and Physiologic Measures

  2014cites this paper
• Increased Oxidative Damage in RNA in Alzheimer's Disease Progression

  2014cites this paper
• The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

  2014cites this paper
• Impaired Glucose Metabolism in Alzheimerâs Disease and Diabetes

  2014cites this paper
• Bioenergetic medicine

  2014cites this paper
• Positron Emission Tomography

  2013cites this paper
• Méthodologie et évaluation clinique de l'imagerie de l'oxygénation cérébrale par IRM

  2013cites this paper
• Astrocyte functions in the copper homeostasis of the brain.

  2013cites this paper
• Aging-related changes of triose phosphate isomerase in hippocampus of senescence accelerated mouse and the intervention of acupuncture.

  2013cites this paper
• Natural abundance in vivo 17 O measurements at 9 . 4 T

  2013cites this paper